BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 9930978)

  • 1. Factor VIIa's first epidermal growth factor-like domain's role in catalytic activity.
    Jin J; Chang J; Chang JY; Kelley RF; Stafford DW; Straight DL
    Biochemistry; 1999 Jan; 38(4):1185-92. PubMed ID: 9930978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four loops of the catalytic domain of factor viia mediate the effect of the first EGF-like domain substitution on factor viia catalytic activity.
    Jin J; Perera L; Stafford D; Pedersen L
    J Mol Biol; 2001 Apr; 307(5):1503-17. PubMed ID: 11292356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
    Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D
    Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of factor VIIa Gla-domain residue Arg-36 for recognition of the macromolecular substrate factor X Gla-domain.
    Ruf W; Shobe J; Rao SM; Dickinson CD; Olson A; Edgington TS
    Biochemistry; 1999 Feb; 38(7):1957-66. PubMed ID: 10026279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the catalytic function of coagulation factor VIIa by a conformational linkage of surface residue Glu 154 to the active site.
    Shobe J; Dickinson CD; Ruf W
    Biochemistry; 1999 Mar; 38(9):2745-51. PubMed ID: 10052945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional consequences of mutations in Ser-52 and Ser-60 in human blood coagulation factor VII.
    Iino M; Foster DC; Kisiel W
    Arch Biochem Biophys; 1998 Apr; 352(2):182-92. PubMed ID: 9587405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant.
    Zhang E; St Charles R; Tulinsky A
    J Mol Biol; 1999 Feb; 285(5):2089-104. PubMed ID: 9925787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of a recombinant human factor VII structural analogue alters its affinity of binding to tissue factor.
    Sridhara S; Chaing S; High KA; Blajchman MA; Clarke BJ
    Am J Hematol; 1996 Oct; 53(2):66-71. PubMed ID: 8892729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of cofactor binding and active site occupancy on the conformation of the macromolecular substrate exosite of factor VIIa.
    Dickinson CD; Shobe J; Ruf W
    J Mol Biol; 1998 Apr; 277(4):959-71. PubMed ID: 9545384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor.
    Iakhiaev A; Ruf W; Rao LV
    Thromb Haemost; 2001 Mar; 85(3):458-63. PubMed ID: 11307815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
    Norledge BV; Petrovan RJ; Ruf W; Olson AJ
    Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ca2+ in the first epidermal growth factor-like domain of activated factor VII.
    Persson E; Nielsen LS
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S79-81. PubMed ID: 9819033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution structure of the N-terminal EGF-like domain from human factor VII.
    Muranyi A; Finn BE; Gippert GP; Forsén S; Stenflo J; Drakenberg T
    Biochemistry; 1998 Jul; 37(30):10605-15. PubMed ID: 9692950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor.
    Banner DW; D'Arcy A; Chène C; Winkler FK; Guha A; Konigsberg WH; Nemerson Y; Kirchhofer D
    Nature; 1996 Mar; 380(6569):41-6. PubMed ID: 8598903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of factor VII's structural domains in tissue factor binding.
    Chang JY; Stafford DW; Straight DL
    Biochemistry; 1995 Sep; 34(38):12227-32. PubMed ID: 7547964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemophilia B with mutations at glycine-48 of factor IX exhibited delayed activation by the factor VIIa-tissue factor complex.
    Wu PC; Hamaguchi N; Yu YS; Shen MC; Lin SW
    Thromb Haemost; 2000 Oct; 84(4):626-34. PubMed ID: 11057861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residues Y179 and H101 of a hydrophobic patch of factor VII are involved in activation by factor Xa.
    Jin J; Chang J; Stafford DW; Straight DL
    Biochemistry; 2001 Sep; 40(38):11405-10. PubMed ID: 11560488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation loop 3 and the 170 loop interact in the active conformation of coagulation factor VIIa.
    Persson E; Olsen OH
    FEBS J; 2009 Jun; 276(11):3099-109. PubMed ID: 19490111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor.
    Stone MD; Harvey SB; Martinez MB; Bach RR; Nelsestuen GL
    Biochemistry; 2005 Apr; 44(16):6321-30. PubMed ID: 15835921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-affinity calcium-binding site in the gama-carboxyglutamic acid domain of bovine factor VII.
    Inoue K; Shimada H; Ueba J; Enomoto S; Tanaka-Saisaka Y; Kubota T; Koyama M; Morita T
    Biochemistry; 1996 Oct; 35(43):13826-32. PubMed ID: 8901525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.